Drug · DIN 02547708
M-RIZATRIPTAN
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since May 16, 2024.
- Drug Identification Number (DIN)
- 02547708
- Company (DIN owner)
- Mantra Pharma Inc.Brossard, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Rizatriptan N02CC04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RIZATRIPTAN (RIZATRIPTAN BENZOATE) | 5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 16, 2024: NOC 33233Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement Between Two Manufacturers
Other DINs named M-RIZATRIPTAN
- DIN 02547716 · Marketed